CN Stock MarketDetailed Quotes

300026 Tianjin Chase Sun Pharmaceutical

Watchlist
  • 4.19
  • -0.11-2.56%
Market Closed Dec 13 15:00 CST
12.59BMarket Cap76.18P/E (TTM)

About Tianjin Chase Sun Pharmaceutical Company

Established in 1996, it was listed on the first batch of GEM in the country in 2009. It is a state-owned enterprise under the State Assets Administration Commission. The controlling shareholder Chengdu Xingcheng Investment Group Co., Ltd. is one of the world's top 500 companies, ranking 493rd. Mainly engaged in the production, operation and research and development of pharmaceuticals and medical devices. The main products include: xibijing injection, moxifloxacin hydrochloride injection (Anrotai), low molecular weight heparin calcium injection (Bopuqing), traditional Chinese medicine formula granules, medical devices, pharmaceutical excipients, etc. Corporate honors: It has won many honors such as a national key high-tech enterprise, a national technological innovation demonstration enterprise, the National Advanced Collective for Poverty Alleviation, the Tianjin Science and Technology Progress Award, and 17th place in the “2023 Top 100 Chinese Medicine Ranking”.

Company Profile

Short Name-A红日药业
Symbol-A300026
Company NameTianjin Chase Sun Pharmaceutical Co., Ltd.
Listing DateOct 30, 2009
Issue Price60.00
Shares Offered12.59M share(s)
FoundedSep 30, 2000
Legal Representativewenyuan wu
General Managerwujun lan
Secretaryyi yang
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativedan liang
Legal CounselBeijing Kangda Law Firm
Employees754
Phone022-59623217
Office AddressTianjin Wuqing Development Zone Venture Headquarters Base Building B01
Zip Code301700
Registered AddressTianjin New Technology Industrial Park Wuqing Development Zone Quanfa Road West
Fax022-59675226
Emailadmin@chasesun.cn
Websitehttp://www.chasesun.cn
Business License120000000002592
BusinessSmall-volume injections, tablets, hard capsules, granules, API production, extraction of traditional Chinese medicines; research, development, consulting and service of bioengineered drugs, genetically-engineered drugs, phytochemicals, chemicals; general freight; the following projects carry out production activities at No. 17 Yuanquan Road, Wuqing Development Zone, Tianjin New Technology Industrial Park: pre-treatment of Chinese herbal medicines; pharmaceutical excipients; large volume injections; small-volume injections; freeze-dried powder injections; chemical products (excluding dangerous goods and easy-to-make drugs) wholesale and retail; import and export of goods and technology (excluding dangerous goods and easy-to-make drugs) (Except as otherwise provided by law or administrative regulations); information systems Operation and maintenance services, software development, information technology consulting services. (The above scope involves the operation of pharmaceuticals with a pharmaceutical production license) (For projects subject to approval according to law, business activities can only be carried out after approval by the relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • wenyuan wu
  • Chairman, Directors, Chairman of the Strategy Committee, Nomination Committee Members
  • --
  • wujun lan
  • Vice Chairman, Directors, General Manager, Strategy Committee Members
  • --
  • chen yao
  • Directors
  • --
  • wu sun
  • Directors, Executive Deputy General Manager, Head of Finance
  • --
  • chunxu li
  • Directors, Deputy General Manager
  • --
  • sen lin
  • Directors, Strategy Committee Members
  • --
  • juan chen
  • Directors
  • --
  • pengfei tu
  • Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Members
  • --
  • li li
  • Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • --
  • shengtian wang
  • Independent Directors, Chairman of the Nomination Committee, Chairman of the Remuneration and Assessment Committee
  • --
  • tao gong
  • Independent Directors, Audit Committee Member
  • --
  • yi yang
  • Board Secretary
  • --
  • dan liang
  • Securities Affairs Representative, Employee Supervisors
  • --
  • wei tan
  • Chairman of the Supervisory Board, Auditors
  • --
  • hui hu
  • Auditors
  • --
  • kun zhang
  • Deputy General Manager
  • --
  • xiaozhong lu
  • Deputy General Manager
  • --
  • ruiqiang chen
  • Deputy General Manager
  • --
Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%